NCT00028262View on ClinicalTrials.gov

Cystagon to Treat Infantile Neuronal Ceroid Lipofuscinosis

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 28, 2001

Primary Completion Date

November 30, 2013

Study Completion Date

November 30, 2013

Conditions
Infantile Neronal Ceroid Lipofuscinosis
Interventions
DRUG

Cystagon

Trial Locations (1)

20892

National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda

All Listed Sponsors
lead

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

NIH

NCT00028262 - Cystagon to Treat Infantile Neuronal Ceroid Lipofuscinosis | Biotech Hunter | Biotech Hunter